Simultaneous Radiotherapy with Continued use of Osimertinib in EGFR-mutated Adenocarcinomas of the Lung

被引：0
|
作者：
Syunyaeva, Z. [1 ,2 ]
Kauffmann-Guerrero, D. [3 ,4 ]
Kahnert, K. [5 ,6 ]
Behr, J. [7 ]
Tufman, A. [8 ,9 ]
机构：
[1] Klinikum Univ Munchen, Med Klin & Poliklin 5, Sekt Pneumol & Thorakale Onkol, Munich, Germany
[2] Lungentumorzentrum Munchen, Munich, Germany
[3] Univ Munich Lmu, Comprehens Pneumol Ctr, Dept Internal Med 5, Munich, Germany
[4] German Ctr Lung Res Dzl, Munich, Germany
[5] Ludwig Maximilians Univ Munchen, Dept Internal Med Resp Med & Thorac Oncol 5, Thorac Oncol Ctr Munich, Munich, Germany
[6] German Ctr Lung Res Dzl Cpc M, Munich, Germany
[7] Klinikum LMU Munchen, Med Klin & Poliklin 5, Comprehens Pneumol Ctr, Munich, Germany
[8] Ludwig Maximilian Univ Munich, Munich, Germany
[9] Ludwig Maximilian Univ Munich, Thorac Oncol Ctr, Div Resp Med & Thorac Oncol, Dept Internal Med 5, Munich, Germany
来源：
PNEUMOLOGIE | 2020年 / 74卷
关键词：
D O I：
10.1055/s-0039-3403365
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P527
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [21] Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
    Planchard, D.
    Janne, P. A.
    Cheng, Y.
    Yang, J. C. -H.
    Yanagitani, N.
    Kim, S-W
    Sugawara, S.
    Yu, Y.
    Fan, Y.
    Geater, S. L.
    Laktionov, K.
    Lee, C. K.
    Valdiviezo, N.
    Ahmed, S.
    Maurel, J-M
    Andrasina, I
    Goldman, J.
    Ghiorghiu, D.
    Rukazenkov, Y.
    Todd, A.
    Kobayashi, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (21): : 1935 - 1948
  • [22] Evaluation of Pneumonitis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Receiving Osimertinib and Thoracic Radiotherapy
    Mak, D. Y.
    Yan, M.
    Cheung, P.
    Parmar, A.
    Poon, I.
    Ung, Y. C.
    Tsao, M.
    Warner, A.
    Louie, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E380 - E381
  • [23] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    British Journal of Cancer, 2019, 121 : 725 - 737
  • [24] Resistance Mechanisms to Osimertinib Treatment in EGFR-Mutated Lung Cancer in a Real Life Cohort
    Steendam, C.
    Atmodimedjo, P.
    Paats, M.
    Van der Leest, C.
    Von der Thusen, J.
    Dinjens, W.
    Van Schaik, R.
    Dubbink, H.
    Aerts, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S562 - S562
  • [25] Chemotherapy with or without immunotherapy or bevacizumab for EGFR-mutated lung cancer after progression on osimertinib
    White, M.
    Neal, J. W.
    Gardner, R. M.
    Cunanan, K. M.
    Das, M.
    Padda, S. K.
    Ramchandran, K.
    Chen, T. T.
    Wakelee, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S773 - S774
  • [26] Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer
    Soria, J. -C.
    Ohe, Y.
    Vansteenkiste, J.
    Reungwetwattana, T.
    Chewaskulyong, B.
    Lee, K. H.
    Dechaphunkul, A.
    Imamura, F.
    Nogami, N.
    Kurata, T.
    Okamoto, I.
    Zhou, C.
    Cho, B. C.
    Cheng, Y.
    Cho, E. K.
    Voon, P. J.
    Planchard, D.
    Su, W. -C.
    Gray, J. E.
    Lee, S. -M.
    Hodge, R.
    Marotti, M.
    Rukazenkov, Y.
    Ramalingam, S. S.
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (02): : 113 - 125
  • [27] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
  • [28] Specific expression of MUC21 in micropapillary elements of lung adenocarcinomas - Implications for the progression of EGFR-mutated lung adenocarcinomas
    Matsumura, Mai
    Okudela, Koji
    Nakashima, Yu
    Mitsui, Hideaki
    Denda-Nagai, Kaori
    Suzuki, Takehisa
    Arai, Hiromasa
    Umeda, Shigeaki
    Tateishi, Yoko
    Koike, Chihiro
    Kataoka, Toshiaki
    Irimura, Tatsuro
    Ohashi, Kenichi
    PLOS ONE, 2019, 14 (04):
  • [29] Adjuvante Therapie mit Osimertinib bei operablem EGFR-mutiertem LungenkarzinomAdjuvant therapy with Osimertinib in resectable EGFR-mutated lung cancer
    Asmae Gassa
    Filiz Özkan
    Hakan Alakus
    Christiane Bruns
    Der Onkologe, 2021, 27 (2): : 172 - 173
  • [30] Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
    Lu, Shun
    Kato, Terufumi
    Dong, Xiaorong
    Ahn, Myung-Ju
    Le-Van Quang
    Soparattanapaisarn, Nopadol
    Inoue, Takako
    Wang, Chih-Liang
    Huang, Meijuan
    Yang, James Chih-Hsin
    Cobo, Manuel
    Ozguroglu, Mustafa
    Casarini, Ignacio
    Dang-Van Khiem
    Sriuranpong, Virote
    Cronemberger, Eduardo
    Takahashi, Toshiaki
    Runglodvatana, Yotsawaj
    Chen, Ming
    Huang, Xiangning
    Grainger, Ellie
    Ghiorghiu, Dana
    van der Gronde, Toon
    Ramalingam, Suresh S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (07): : 585 - 597
12345